MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha

Bioengineered. 2022 Apr;13(4):10061-10070. doi: 10.1080/21655979.2022.2063537.

Abstract

Lung adenocarcinoma (LUAD) severely threatens the health of people owing to its lethality. Nonetheless, the underlying mechanisms on LUAD development remain unclear to a great extent. This work aimed to probe the functions of miR-218-5p in LUAD. MiR-218-5p and endoplasmic reticulum oxidoreductase 1 alpha (ERO1A) were screened as differently downregulated and upregulated RNAs in LUAD, respectively, by bioinformatics analyses. The results of cell functional assays stated that enforced expression of miR-218-5p notably restrained cell viability, invasion, and migration in LUAD. MiR-218-5p may interact with 3'-untranslated region of ERO1A mRNA as analyzed by bioinformatics. Afterward, western blot and dual-luciferase reporter gene analyses were introduced to identify their interaction. ERO1A overexpression reversed the suppressive impacts of miR-218-5p on LUAD cell progression, indicating the implication of miR-218-5p/ERO1A axis in suppressing cancer development. We also observed that this regulatory axis suppressed angiogenesis in LUAD. Taken together, miR-218-5p/ERO1A axis exerted an imperative role in LUAD cell progression, which provides a valuable clue for the development of LUAD therapeutic regimen.

Keywords: ERO1A; lung adenocarcinoma; malignant progression; mechanism; miR-218-5p.

MeSH terms

  • Adenocarcinoma of Lung* / metabolism
  • Adenocarcinoma*
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Endoplasmic Reticulum / metabolism
  • Humans
  • Lung Neoplasms* / pathology
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Oxidoreductases

Substances

  • MIRN218 microRNA, human
  • MicroRNAs
  • Oxidoreductases

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.